LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

Search

Cytek Biosciences Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

4.51 4.4

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.23

Max

4.57

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-39M

-44M

Pardavimai

9.8M

62M

Pelnas, tenkantis vienai akcijai

-0

Pelno marža

-70.929

Darbuotojai

702

EBITDA

4M

-263K

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+44.01% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-30M

531M

Ankstesnė atidarymo kaina

0.11

Ankstesnė uždarymo kaina

4.51

Naujienos nuotaikos

By Acuity

50%

50%

155 / 350 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

Cytek Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-19 18:34; UTC

Uždarbis

Canada to Allow Smaller Companies to Ax Quarterly Earnings Reports in Pilot

2026-03-19 17:43; UTC

Pagrindinės rinkos jėgos

Ecolab Dips on Report of Deal for CoolIT Systems With KKR

2026-03-19 23:47; UTC

Uždarbis

COSCO SHIPPING Holdings: Geopolitical Tensions Will Continue Driving Regional Fragmentation >1919.HK

2026-03-19 23:47; UTC

Uždarbis

COSCO SHIPPING Holdings: Container Shipping Market Saw Fluctuating, Declining Freight Rates >1919.HK

2026-03-19 23:47; UTC

Uždarbis

COSCO SHIPPING Holdings 2025 Rev CNY219.50B Vs. CNY233.86B >1919.HK

2026-03-19 23:47; UTC

Uždarbis

COSCO SHIPPING Holdings 2025 Net CNY30.86B Vs. Net CNY49.17B >1919.HK

2026-03-19 23:39; UTC

Uždarbis

Li Ning 2025 Net CNY2.94B Vs. Net CNY3.01B >2331.HK

2026-03-19 23:39; UTC

Uždarbis

Li Ning: Will Continue Targeting Consumer Needs, Strengthening User Engagement >2331.HK

2026-03-19 23:39; UTC

Uždarbis

Li Ning: Outdoor Category Continued Growing >2331.HK

2026-03-19 23:38; UTC

Uždarbis

Li Ning 2025 Rev CNY29.60B Vs. CNY28.68B >2331.HK

2026-03-19 23:33; UTC

Rinkos pokalbiai

Gold Edges Lower on Inflation Concerns, Dimmed Fed Rate-Cut Hopes -- Market Talk

2026-03-19 22:42; UTC

Įsigijimai, susijungimai, perėmimai

Unilever in Talks to Separate Food Business and Combine It With McCormick -- WSJ

2026-03-19 22:42; UTC

Įsigijimai, susijungimai, perėmimai

McCormick Has a Market Value of Around $14.8B -- WSJ

2026-03-19 22:42; UTC

Įsigijimai, susijungimai, perėmimai

Unilever in Talks to Combine Food Business With McCormick, Sources Say -- WSJ

2026-03-19 22:42; UTC

Įsigijimai, susijungimai, perėmimai

All-Stock Unilever-McCormick Deal Could Come Together Within Weeks, Sources Say -- WSJ

2026-03-19 22:23; UTC

Rinkos pokalbiai

FedEx Says It Can Raise Prices to Offset Higher Fuel Costs -- Market Talk

2026-03-19 22:09; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Australian Transport Stocks to Trade at Discount On Fuel Risks -- Market Talk

2026-03-19 22:06; UTC

Rinkos pokalbiai

Sigma Healthcare's New Bull Expects Profit Margins to Widen -- Market Talk

2026-03-19 22:04; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

FedEx CFO: MD-11 Grounding Led to $120M Headwind to Adjusted Operating Income in 3Q

2026-03-19 22:03; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Energy Roundup: Market Talk

2026-03-19 22:03; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Fuel Prices, Scarcity Could Leave Mark on Australia's Gold Miners -- Market Talk

2026-03-19 21:51; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

FedEx CEO: InPost Deal Expected to Be Accretive to Earnings in Year One After Close

2026-03-19 20:57; UTC

Svarbiausios naujienos

Middle East Attacks, Inflation Fears Weigh on Stocks -- WSJ

2026-03-19 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-19 20:19; UTC

Svarbiausios naujienos

Brent Crude Retreats After Touching $119 -- WSJ

2026-03-19 19:49; UTC

Rinkos pokalbiai

Brent Crude Seen Potentially Rising to Top Its 2008 High -- Market Talk

2026-03-19 19:26; UTC

Svarbiausios naujienos

U.S. Consumers Face 'Global Oil Shock.' The Iran War Is Retail's Latest Challenge. -- Barrons.com

2026-03-19 19:10; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Natural Gas Rises in Volatile Trading -- Market Talk

2026-03-19 19:06; UTC

Svarbiausios naujienos

Brent Crude Prices Are Surging. Why Europe Is Facing an Energy Shock and the U.S. Isn't. -- Barrons.com

2026-03-19 18:08; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Silver Extends Slide to Seven Straight Sessions -- Market Talk

Akcijų palyginimas

Kainos pokytis

Cytek Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

44.01% į viršų

12 mėnesių prognozė

Vidutinis 6.25 USD  44.01%

Aukščiausias 7.5 USD

Žemiausias 5 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Cytek Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

1

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

3.7 / 3.8Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

155 / 350 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat